Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03527147
Title Platform Study for the Treatment of Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma (PRISM Study)
Acronym PRISM
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Acerta Pharma BV
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | GBR


No variant requirements are available.